Ortega et al., 2013 - Google Patents
Epidemiology and prognostic determinants of bacteraemic catheter-acquired urinary tract infection in a single institution from 1991 to 2010Ortega et al., 2013
- Document ID
- 15728766076512648048
- Author
- Ortega M
- Marco F
- Soriano A
- Almela M
- Martinez J
- Pitart C
- Mensa J
- Publication year
- Publication venue
- Journal of Infection
External Links
Snippet
Objectives To determine the epidemiology of bacteraemic Catheter-Acquired Urinary Tract Infection (CA-UTI) and to identify independent predictors of mortality. Methods This study was part of a bloodstream infection surveillance study that prospectively collected data on …
- 206010046577 Urinary tract infection 0 title abstract description 11
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ortega et al. | Epidemiology and prognostic determinants of bacteraemic catheter-acquired urinary tract infection in a single institution from 1991 to 2010 | |
| Grasselli et al. | Hospital-acquired infections in critically ill patients with COVID-19 | |
| Bonkat et al. | Management of Urosepsis in 2018 | |
| Ortega et al. | Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome | |
| Ortega et al. | Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008 | |
| Bader et al. | An update on the management of urinary tract infections in the era of antimicrobial resistance | |
| Fraser et al. | Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay | |
| Zhong et al. | Multidrug-resistant gram-negative bacterial infections after liver transplantation–spectrum and risk factors | |
| Deliberato et al. | Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting | |
| Azoulay et al. | Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia | |
| Degoricija et al. | Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy | |
| Xie et al. | Ventilator-associated pneumonia in intensive care units in Hubei Province, China: a multicentre prospective cohort survey | |
| Flanders et al. | Nosocomial pneumonia: state of the science | |
| Ena et al. | Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli | |
| Tandogdu et al. | Urinary tract infections in immunocompromised patients with diabetes, chronic kidney disease, and kidney transplant | |
| Kollef et al. | Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study | |
| Ortega et al. | Epidemiology and prognostic determinants of bacteraemic biliary tract infection | |
| Simonetti et al. | Declining mortality among hospitalized patients with community-acquired pneumonia | |
| Makris et al. | The impact of COPD on ICU mortality in patients with ventilator-associated pneumonia | |
| Park et al. | How to interpret the bile culture results of patients with biliary tract infections | |
| Neuzillet et al. | French results of the ARESC study: clinical aspects and epidemiology of antimicrobial resistance in female patients with cystitis. Implications for empiric therapy | |
| Dabar et al. | Community-and healthcare-associated infections in critically ill patients: a multicenter cohort study | |
| Lee et al. | Impact of inappropriate empirical antibiotic therapy on outcome of bacteremic adults visiting the ED | |
| Horino et al. | Predictive factors for metastatic infection in patients with bacteremia caused by methicillin-sensitive Staphylococcus aureus | |
| Tanriover et al. | Epidemiology and outcome of sepsis in a tertiary-care hospital in a developing country |